NCT01751113 - A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone propionate/salmeterol

250mcg fluticasone + 50 mcg salmeterol, twice daily 4 week treatment in each treatment sequence (crossover design)

DRUG

tiotropium bromide

18 mcg tiotropium bromide, once daily 4 week treatment in each treatment sequence (crossover design)

DRUG

fluticasone propionate/salmeterol plus tiotropium bromide

250mcg fluticasone + 50 mcg salmeterol, twice daily plus 18 mcg tiotropium bromide, once daily 4 week treatment in each treatment sequence (crossover design)

Trial Locations (3)

070-8644

GSK Investigational Site, Hokkaido

319-1113

GSK Investigational Site, Ibaraki

530-0001

GSK Investigational Site, Osaka